Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alzheimer Disease 5”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04341389
What this trial is testing

A Phase II Clinical Trial to Evaluate the Recombinant Vaccine for COVID-19 (Adenovirus Vector)

Who this might be right for
COVID-19
Institute of Biotechnology, Academy of Military Medical Sciences, PLA of China 508
Early research (Phase 1)Study completedNCT02326194
What this trial is testing

A Phase I Clinical Trial to Evaluate the Ebola Adenovirus Vector Vaccine (Ad5-EBOV) in Healthy Adults.

Who this might be right for
Ebola Virus Disease
Jiangsu Province Centers for Disease Control and Prevention 120
Testing effectiveness (Phase 2)UnknownNCT02844699
What this trial is testing

Randomized Double-blind Placebo-controlled Pilot Study of Safety, Pharmacodynamics and Efficacy of Different Treatments of Immunotherapeutic Drug Mobilan (M-VM3) in Patients With Diagnosed Prostate Cancer

Who this might be right for
Prostate Cancer
Panacela Labs LLC 24
Testing effectiveness (Phase 2)Study completedNCT00165659
What this trial is testing

A Multi-Center, Randomized, Double-Blind, Parallel Group Study With 3 Groups Receiving Placebo, 5 mg of E2020 and 10 mg of E2020

Who this might be right for
Alzheimer Disease
Eisai Limited
Early research (Phase 1)Study completedNCT00964756
What this trial is testing

An Infectivity Enhanced Suicide Gene Expressing Adenovirus for Ovarian Cancer in Patients With Recurrent Ovarian and Other Selected Gynecologic Cancers

Who this might be right for
Ovarian Cancer
University of Alabama at Birmingham 11
Not applicableStudy completedNCT03578991
What this trial is testing

Diabetes as an Accelerator of Cognitive Impairment and Alzheimer's Disease

Who this might be right for
Patients Aged 65-85 (Both Included)Diagnosed of Mild Cognitive ImpairmentDiagnosed of Type 2 Diabetes in Active Treatment (Hypoglycemic Agents) for a Period ≥5 Years
Parc Sanitari Pere Virgili 54
Post-approval studies (Phase 4)Study completedNCT00234637
What this trial is testing

Rivastigmine Monotherapy and Combination Therapy With Memantine in Patients With Moderately Severe Alzheimer's Disease Who Failed to Benefit From Previous Cholinesterase Inhibitor Treatment

Who this might be right for
Alzheimer's Disease
Novartis 204
Testing effectiveness (Phase 2)Study completedNCT00742417
What this trial is testing

Efficacy and Safety of Plasma Exchange With 5% Albumin in Beta-amyloid Peptide Clearance in Cerebral Spinal Fluid

Who this might be right for
Alzheimer's Disease
Instituto Grifols, S.A. 42
Early research (Phase 1)Study completedNCT00801697
What this trial is testing

Safety and Immune Response to Preventive HIV Immunization With Adenovirus Serotype 5 or 35 Vector

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 192
Early research (Phase 1)Study completedNCT00894114
What this trial is testing

Safety, Tolerability and Immunogenicity of a 1-Dose Regimen of MRKAd5 HIV-1 Gag Vaccine Versus the ALVAC_HIV Vaccine (V520-019)

Who this might be right for
HIV-1 Infection
Merck Sharp & Dohme LLC 250
Large-scale testing (Phase 3)Study completedNCT00428389
What this trial is testing

Safety of Switching From Donepezil to Rivastigmine Patch in Patients With Probable Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Novartis 262
Large-scale testing (Phase 3)Study completedNCT05204589
What this trial is testing

Heterologous Boost Immunization with an Aerosolised Ad5-nCoV After Two-dose Priming with an Inactivated SARS-CoV-2 Vaccine

Who this might be right for
COVID-19
Jiangsu Province Centers for Disease Control and Prevention 10,285
Early research (Phase 1)Study completedNCT02005991
What this trial is testing

Examine The Distribution Of PF-05212377 In The Brain Of Healthy Volunteer Subjects Using Positron Emission Tomography And A Radioactive Tracer Following Oral Administration Of One Dose Of PF-05212377

Who this might be right for
Healthy
Pfizer 4
Large-scale testing (Phase 3)Study completedNCT01245530
What this trial is testing

An Efficacy and Safety Study of INM-176 for the Treatment of Patients With Alzheimer Type Dementia

Who this might be right for
Alzheimer Type Dementia
Whanin Pharmaceutical Company 280
Not applicableStudy completedNCT00039702
What this trial is testing

Brain Imaging in Alzheimer's Disease

Who this might be right for
Alzheimer Disease
National Institute of Mental Health (NIMH) 40
Post-approval studies (Phase 4)Study completedNCT04892459
What this trial is testing

Study on Sequential Immunization of Inactivated SARS-CoV-2 Vaccine and Recombinant SARS-CoV-2 Vaccine (Ad5 Vector)

Who this might be right for
COVID-19
Jiangsu Province Centers for Disease Control and Prevention 300
Early research (Phase 1)Study completedNCT02533791
What this trial is testing

A Booster Dose of Ad5-EBOV in Healthy Adults After Primary Immunization

Who this might be right for
Ebola Virus Disease
Jiangsu Province Centers for Disease Control and Prevention 110
Large-scale testing (Phase 3)WithdrawnNCT03360448
What this trial is testing

AC6 Gene Transfer in Patients With Reduced Left Ventricular Ejection Fraction Heart Failure

Who this might be right for
Heart Failure
Renova Therapeutics
Post-approval studies (Phase 4)Study completedNCT00948766
What this trial is testing

Effects of Rivastigmine Patch on Activities of Daily Living and Cognition in Patients With Severe Dementia of the Alzheimer's Type (ACTION) (Study Protocol CENA713DUS44, NCT00948766) and a 24 Week Open-label Extension to Study CENA713DUS44

Who this might be right for
Alzheimer's Disease
Novartis 716
Testing effectiveness (Phase 2)Ended earlyNCT00095576
What this trial is testing

Investigation of V520 in an HIV Vaccine Proof-of-Concept Study (V520-023)

Who this might be right for
AIDSHIV Infections
Merck Sharp & Dohme LLC 3,000
Next Page